Page last updated: 2024-09-04

resiquimod and Kahler Disease

resiquimod has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bohnhorst, J; Børset, M; Espevik, T; Fløttum, M; Knudsen, L; Moen, SH; Rasmussen, T; Sundan, A	1

Other Studies

1 other study(ies) available for resiquimod and Kahler Disease

Article	Year
Toll-like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia, 2006, Volume: 20, Issue:6 Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Dipeptides; Flagellin; Gene Expression Profiling; Humans; Imidazoles; Interleukin-6; Ligands; Lipopeptides; Lipopolysaccharides; Lipoproteins; Membrane Glycoproteins; Multiple Myeloma; Oligodeoxyribonucleotides; Oligopeptides; Poly I-C; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Syndecans; Toll-Like Receptors	2006

Article

Year

Toll-like receptors mediate proliferation and survival of multiple myeloma cells.

Leukemia, 2006, Volume: 20, Issue:6

Topics: Cell Line, Tumor; Cell Proliferation; Cell Survival; Dipeptides; Flagellin; Gene Expression Profiling; Humans; Imidazoles; Interleukin-6; Ligands; Lipopeptides; Lipopolysaccharides; Lipoproteins; Membrane Glycoproteins; Multiple Myeloma; Oligodeoxyribonucleotides; Oligopeptides; Poly I-C; Proteoglycans; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Syndecans; Toll-Like Receptors

2006